Literature DB >> 17329453

Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates.

Nathan A Ledeboer1, Kingshuk Das, Michael Eveland, Céline Roger-Dalbert, Sandrine Mailler, Sonia Chatellier, William Michael Dunne.   

Abstract

The development of reliable and rapid methods for the identification of patients colonized with vancomycin-resistant enterococci (VRE) is central to the containment of this agent within a hospital environment. To this end, we evaluated a prototype chromogenic agar medium (VRE-BMX; bioMérieux, Marcy l'Etoile, France) used to recover VRE from clinical specimens. This medium can also identify isolated colonies as either vancomycin-resistant Enterococcus faecium or Enterococcus faecalis, based on distinct colony colors. We compared the performance of VRE-BMX with bile esculin azide agar supplemented with vancomycin (BEAV). For this study, 147 stool samples were plated on each test medium and examined after 24 and 48 h of incubation. At 24 h, the sensitivity and specificity of each medium were as follows: BEAV, 90.9% and 89.9%, respectively; VRE-BMX, 96.4% and 96.6%, respectively. The positive predictive values (PPV) of VRE-BMX and BEAV at 24 h were 89.8% and 80.7%, respectively. VRE-BMX provided the identification of 10 isolates of vancomycin-resistant E. faecalis and 4 isolates of vancomycin-resistant E. faecium that were not recovered by BEAV. Further, VRE-BMX was capable of identifying patients colonized with both E. faecium and E. faecalis, a feature useful for infection control purposes that is not a function of BEAV. In terms of the recovery of vancomycin-resistant E. faecium and E. faecalis, the sensitivity and PPV were as follows: BEAV, 75.7% and 74.6%, respectively; VRE-BMX, 95.5% and 91.3%, respectively. In this initial evaluation, we found that VRE-BMX provided improved recovery of VRE from stool specimens, with the added advantage of being able to differentiate between vancomycin-resistant E. faecalis and E. faecium. Extending the incubation period beyond 24 h did not significantly improve the recovery of VRE and resulted in decreased specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329453      PMCID: PMC1865861          DOI: 10.1128/JCM.02116-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System.

Authors: 
Journal:  Am J Infect Control       Date:  1999-12       Impact factor: 2.918

2.  Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target.

Authors:  C Poyart; G Quesne; C Boumaila; P Trieu-Cuot
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 3.  Genetics of glycopeptide resistance in gram-positive pathogens.

Authors:  Patrice Courvalin
Journal:  Int J Med Microbiol       Date:  2005-03       Impact factor: 3.473

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

5.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

6.  Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization.

Authors:  M Webb; L W Riley; R B Roberts
Journal:  Clin Infect Dis       Date:  2001-07-11       Impact factor: 9.079

7.  A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

Authors:  S M Bhavnani; J A Drake; A Forrest; J A Deinhart; R N Jones; D J Biedenbach; C H Ballow
Journal:  Diagn Microbiol Infect Dis       Date:  2000-03       Impact factor: 2.803

8.  Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.

Authors:  Xiaoyan Song; Arjun Srinivasan; David Plaut; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

9.  Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs.

Authors:  L M Sloan; J R Uhl; E A Vetter; C D Schleck; W S Harmsen; J Manahan; R L Thompson; J E Rosenblatt; F R Cockerill
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Health and economic outcomes of vancomycin-resistant enterococci.

Authors:  Yehuda Carmeli; George Eliopoulos; Essy Mozaffari; Matthew Samore
Journal:  Arch Intern Med       Date:  2002-10-28
View more
  12 in total

1.  Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Jess F Peterson; Christopher D Doern; George Kallstrom; Katherine M Riebe; Tara Sander; William Michael Dunne; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 2.  Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species.

Authors:  Surbhi Malhotra-Kumar; Kelly Haccuria; Mindy Michiels; Margareta Ieven; Claire Poyart; Waleria Hryniewicz; Herman Goossens
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

3.  Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs.

Authors:  E A Grabsch; S Ghaly-Derias; W Gao; B P Howden
Journal:  J Clin Microbiol       Date:  2008-10-01       Impact factor: 5.948

4.  Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens.

Authors:  Heidrun Peltroche-Llacsahuanga; Janetta Top; Josefine Weber-Heynemann; Rudolf Lütticken; Gerhard Haase
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

Review 5.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

6.  Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in Enterococci.

Authors:  Thamara M Wijesuriya; Peta Perry; Todd Pryce; John Boehm; Ian Kay; James Flexman; Geoffrey W Coombs; Paul R Ingram
Journal:  J Clin Microbiol       Date:  2014-05-28       Impact factor: 5.948

7.  Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta- lactamase-producing Enterobacteriaceae.

Authors:  Te-Din Huang; Pierre Bogaerts; Catherine Berhin; Amelie Guisset; Youri Glupczynski
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

8.  Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs.

Authors:  Yesim Cekin; Aylin Erman Daloğlu; Dilara Oğünç; Betil Ozhak Baysan; Duygu Dağlar; Dilara Inan; Derya Mutlu; Gözde Ongüt; Dilek Colak
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

9.  Automated Scoring of Chromogenic Media for Detection of Methicillin-Resistant Staphylococcus aureus by Use of WASPLab Image Analysis Software.

Authors:  Matthew L Faron; Blake W Buchan; Chiara Vismara; Carla Lacchini; Alessandra Bielli; Giovanni Gesu; Theo Liebregts; Anita van Bree; Arjan Jansz; Genevieve Soucy; John Korver; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

10.  Evaluation of a PCR assay to detect enterococcusfaecalis in blood and determine glycopeptides resistance genes: van a and van B.

Authors:  Hamidreza Honarm; Mahsome Falah Ghavidel; Iraj Nikokar; Morteza Rahbar Taromsari
Journal:  Iran J Med Sci       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.